Research & Development: Page 76
-
PharmaVoice Team/PharmaVoice
E-Media
New Electronic and Web-based Applications, Sites, and Technologies Featured Briefs: Model N Application Provides Strategic Insights to Life-Sciences Firms New Momentum Offers AntiCounterfeiting Software Novartis Launches Meningitis Website Website Highlights Pink Tank’s Expertise in Women’s Healt...
By PharmaVoice Team • April 23, 2009 -
PharmaVoice Team/PharmaVoice
PharmaTrax
Sales, Marketing, and R&D Trends from Industry Analysts Featured Briefs: Electronic Delivery of CME Gains Popularity Sidebar: Average % of CME Delivered Via Internet Smaller, Refocused Salesforces Could Create Greater Value for Patients Sidebar: Pharma Job Cuts Announced as of October 2008 Ef...
By PharmaVoice Team • April 23, 2009 -
Explore the Trendline➔
Stock via Getty Images
TrendlineArtificial intelligence & machine learning
After years of excited buzz around the potential of artificial intelligence and machine learning, pharma has begun to realize the true implications and potential value of these technologies.
By PharmaVoice staff -
PharmaVoice Team/PharmaVoice
UpFront
Milestones 10th anniversary marked with rebranding GxP Consulting (formerly GxPi Ltd.), a provider of compliance services to the pharma and biopharma industries, has launched its newly designed and improved Website and a new name as it celebrates 10 years in business. The new Website, accessible ...
By PharmaVoice Team • April 23, 2009 -
PharmaVoice Team/PharmaVoice
Differentiating KOLs and Advocates: The Importance of a Targeted Strategy
The terms key opinion leader (KOL) and advocate are often used interchange ably; but, they define t w o very different target groups. A strategy to clearly identify and characterize KOLs, to then con vert them to and deploy them as advocates, and finally to build and maintain a lasting relationsh...
By PharmaVoice Team • April 14, 2009 -
PharmaVoice Team/PharmaVoice
Physician Learning: Improving the Process
This program will profoundly improve my practice of medicine. It was exactly what I was looking for,” a primarycare physi cian recently stated as he was leaving a continuing medical education (CME) pro gram on hypertension. This is a high compliment indeed and a goal that all CME providers strive...
By PharmaVoice Team • April 14, 2009 -
PharmaVoice Team/PharmaVoice
Delivering CME to Physicians: A Look at the Future
Continuing medical education has always sought to provide physicians with accurate, targeted learning opportuni ties. But delivering that critical infor mation is becoming more difficult. Many commercial supporters have already changed how they support CME because of the OIG, PhRMA guidelines, co...
By PharmaVoice Team • April 14, 2009 -
PharmaVoice Team/PharmaVoice
Mission Possible: Transform the Clinical-Trial Process
The mission of the Clinical Trials Transformation Initiative (CTTI) is to identify practices that will increase the quality and efficiency of clinical trials. According to the organization, its first year was defined by great stakeholder enthusiasm, a strong organizational foundation, and rapid p...
By PharmaVoice Team • March 25, 2009 -
PharmaVoice Team/PharmaVoice
Dr. George Scangos: Gene Excellence
BY KIM RIBBINK With a practical approach to research and discovery, Dr. George Scangos has led Exelixis from a genomic research firm to a drug discovery and development company with expertise in oncology and metabolism. Research, by necessity, can often be an esoteric pursuit. But for George Scan...
By Kim Ribbink • March 25, 2009 -
PharmaVoice Team/PharmaVoice
Table of Contents
In Every Issue 3 Letter from the Editor 8 Upfront A brief review of industry news at press time 34 PharmaOutlet Kit Howard looks at what makes professional certification valuable. 36 PharmaTrax Sales, marketing, and R&D trends from industry analysts 38 What’s New New healthcare-related produc...
By PharmaVoice Team • March 25, 2009 -
PharmaVoice Team/PharmaVoice
Last Word
Novartis Oncology’s David Epstein discusses the growing relevance of diagnostics in drug development. Mr. Epstein credits breakthroughs in biology and bioinformatics with an increased understanding of the genome that will enable developers to do a better job of matching the right drug with the ri...
By PharmaVoice Team • March 25, 2009 -
PharmaVoice Team/PharmaVoice
E-Media
New electronic and web-based applications, sites, and technologies Knexus Provides Business-to-Business Social Media Platform Knexus Tech has introduced a business-to-business (B2B) social media platform that gives companies a quick, easy way to engage busy business professionals with quality ins...
By PharmaVoice Team • March 25, 2009 -
PharmaVoice Team/PharmaVoice
PharmaTrax
Sales, marketing, And R&D Trends affecting the healthcare industry Verified Physicians Ensure Quality Data As online physician panels gain popularity among pharmaceutical and medical device companies that conduct Web-based surveys, research shows there is little interest in verifying that the...
By PharmaVoice Team • March 25, 2009 -
PharmaVoice Team/PharmaVoice
PharmaOutlet
Contributed by Kit Howard, M.S., CCDM, CRCP What makes professional certification valuable? In recent years, there has been a proliferation of certification programs within the pharma/biotech/devices world. Some are broad-based, such as project management (e.g., the Project Management Institute’s...
By Kit Howard • March 25, 2009 -
PharmaVoice Team/PharmaVoice
UpFront
Investment Portfolio R&D Spending by U.S. Biopharmaceutical Companies Increases 3% in 2008 A new report reveals that R&D investment in new medicines by the biopharmaceutical industry was $65.2 billion in 2008, an increase of 3% from 2007, according to a combined analysis conducted by Burr...
By PharmaVoice Team • March 25, 2009 -
PharmaVoice Team/PharmaVoice
Advair: The Drug to Watch
The inhaler is well on its way to blockbuster status in the U.S., where it debuted in April 2001. Advair Diskus already is the fastestgrowing asthma medicine in Europe, where it is marketed under the name Seretide, and Goldman Sachs analysts fore cast that global sales of the drug will reach $2.4...
By Lynda Sears • March 17, 2009 -
PharmaVoice Team/PharmaVoice
E-Media
NEW ELECTRONIC AND WEBBASED APPLICATIONS, SITES, AND TECHNOLOGIES ePocrates To Collaborate With Express Scripts on HANDHELD FORMULARY INITIATIVE ePocrates has agreed to incorporate the formu lary information of Express Scripts Inc., a national pharmacy benefits manager, into the ePocrates Rx Form...
By PharmaVoice Team • March 11, 2009 -
PharmaVoice Team/PharmaVoice
What's New
Ventiv Health Inc., MDS Pharma Services,and Paul Capital Partners have joined forces to provide lifesci ences companies with a broad range of development, commercialization,and investment support. The alliance combines the drug discovery and development expertise of MDS Pharma Services,the commer...
By PharmaVoice Team • March 11, 2009 -
PharmaVoice Team/PharmaVoice
Defining GLOBAL
BY DENISE MYSHKO AND ROBIN ROBINSON KARLA ANDERSON Managing Director, Life Sciences BearingPoint Global is a perspective of looking at the business in its totality, not just at a given market or a given country or a given set of rules and regulations, but at the business as a whole. It’s always c...
By Denise Myshko and Robin Robinson • March 1, 2009 -
PharmaVoice Team/PharmaVoice
Global Thought leaders
Karla Anderson, Managing Director, Life Sciences, BearingPoint Inc. — A provider of management and technology consulting services. For more information, visit bearingpoint.com. Leone Atkinson, M.D., Senior Director of Clinical Development, PTC Therapeutics Inc. — A biopharmaceutical company focus...
By PharmaVoice Team • Feb. 27, 2009 -
PharmaVoice Team/PharmaVoice
An Approach to Language in GLOBAL Trials
Informed consent procedure requires that written consent be translated into the patient’s native language, and any unique cultural aspects be taken into account. In addition, many countries have multiple language translation requirements, depending on the population demographics. When linguistic ...
By PharmaVoice Team • Feb. 26, 2009 -
PharmaVoice Team/PharmaVoice
GLOBAL Patient Recruitment
BY DENISE MYSHKO Patient recruitment has and will continue to evolve in a global marketplace, with all countries competing equally and being measured on performance for the quality of patients screened and recruited within the shortest amount of time. “The U.S. market was the most developed in te...
By Denise Myshko • Feb. 26, 2009 -
PharmaVoice Team/PharmaVoice
GLOBAL Talent
As companies globalize and seek to maximize the opportunities and challenges that result, they need to ensure that they have an understanding of the talent potential that exists globally. All too often companies think in local operating terms or seek to attract talent within the country where the...
By PharmaVoice Team • Feb. 26, 2009 -
PharmaVoice Team/PharmaVoice
Talent Pool
Pharmaceutical POOL Deirdre CONNELLY GlaxoSmithKline Selects Head of North American Pharma Business Deirdre Connelly, former president of U.S. operations at Eli Lilly, has joined GlaxoSmithKline (GSK) as president, North American pharmaceuticals. Ms. Connelly was appointed president of U.S. opera...
By PharmaVoice Team • Feb. 26, 2009 -
PharmaVoice Team/PharmaVoice
E-media
New electronic and web-based applications, sites, and technologies Ziment Unveils New Market Research Tool Ziment has introduced an analytic technique, SequenceZ, which allows forecasters to make better use of market research by providing more accurate assessments of the effect of product launch ...
By PharmaVoice Team • Feb. 26, 2009 -
PharmaVoice Team/PharmaVoice
What's New
New healthcare-related products, services, and companies GfK Consolidates Market Research Operations Operating as one entity allows GfK Healthcare to pull together its strengths and individual leadership positions across multi-client research. The GfK U.S. Healthcare Companies has consolidated it...
By PharmaVoice Team • Feb. 26, 2009
Previous
